HELIUS MEDICAL TECHNOLOGIES, INC. (OTCMKTS:HSDT) Files An 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

Item 5.02 Departure of Directors or Certain Officers; Election of
Directors; Appointment of Certain Officers; Compensatory
Arrangements of Certain Officers.

On January 30, 2017, Helius Medical Technologies, Inc. (the
Company) received a written letter of resignation from Savio Chiu
stating that he has resigned from his position on the Companys
Board of Directors (the Board), effective immediately.Mr. Chiu
resigned from the Board to pursue other business
opportunities.Mr. Chius resignation did not result from any
disagreement with the Company.

Item 9.01 Financial Statements and Exhibits.

About HELIUS MEDICAL TECHNOLOGIES, INC. (OTCMKTS:HSDT)

Helius Medical Technologies, Inc. is a medical technology company focused on neurological wellness. The Company focuses on developing, licensing or acquiring non-invasive platform technologies that amplify the brain’s ability to heal itself. The Company is engaged in the development of its product, the portable neuromodulation stimulator (PoNS) device. The device, when used in combination with physiotherapy, is designed to enhance the brain’s ability to compensate for damage due to trauma or disease. The Company’s PoNS device is designed to induce cranial nerve non-invasive neuromodulation through an increase in stimulation of the facial and trigeminal nerves, which innervate the tongue. The PoNS device is developed to deliver to the tongue a non-invasive neurostimulation, in a form that induces neuromodulation. The PoNS device is an electrical pulse generator that delivers controlled electrical stimulation to the tongue.

HELIUS MEDICAL TECHNOLOGIES, INC. (OTCMKTS:HSDT) Recent Trading Information

HELIUS MEDICAL TECHNOLOGIES, INC. (OTCMKTS:HSDT) closed its last trading session up +0.01 at 1.75 with 1,500 shares trading hands.